Background: Coronavirus Disease-2019 (COVID-19) has been associated with myocardial injury and higher risk of arrhythmic complications. However, no reports are available about the effect of the ongoing pandemic on arrhythmias in patients at risk. Objective: To describe the effect of COVID-19 pandemic on arrhythmic burden among high-risk patients. Methods: This is a cross-sectional study on the incidence of ventricular arrhythmia (VA) during the pandemic outbreak (study period), compared to the same timeframe in 2019 (reference period). Inclusion criteria were age (>18 years) and having an implantable cardiac defibrillator (ICD). Results: Among 455 patients enrolled (mean age 64.9 ± 15.7 years; 25.1% females and 39.6% with CRTD), in the study period, 45 (9.9%) patients experienced a total of 86 VA; 8 patients (1.7%) required antitachycardia-pacing (ATP) and 6 (1.3%) at least one shock. In the reference period, a total of 69 events occurred in 36 patients (7.9%). Six patients (1.3%) required ATP and three (0.7%) at least one shock. The number of patients that suffered from any arrhythmic events in the study period (9.9% vs 7.9%) did not significantly differ from the reference period (χ2 = 1.09, P =.29). The main predictor of VA during the COVID-19 pandemic was the previous history of any ICD therapy (OR = 3.84, P <.001). Conclusions: No evidence of an increase of arrhythmic burden was found during the COVID-19 pandemic among patients with an ICD.

Malanchini, G., Ferrari, P., Leidi, C., Ferrari, G., Racheli, M., Senni, M., et al. (2021). Ventricular arrhythmias among patients with implantable cardioverter-defibrillator during the COVID-19 pandemic. JOURNAL OF ARRHYTHMIA, 37(2), 407-413 [10.1002/joa3.12518].

Ventricular arrhythmias among patients with implantable cardioverter-defibrillator during the COVID-19 pandemic

Senni M;
2021

Abstract

Background: Coronavirus Disease-2019 (COVID-19) has been associated with myocardial injury and higher risk of arrhythmic complications. However, no reports are available about the effect of the ongoing pandemic on arrhythmias in patients at risk. Objective: To describe the effect of COVID-19 pandemic on arrhythmic burden among high-risk patients. Methods: This is a cross-sectional study on the incidence of ventricular arrhythmia (VA) during the pandemic outbreak (study period), compared to the same timeframe in 2019 (reference period). Inclusion criteria were age (>18 years) and having an implantable cardiac defibrillator (ICD). Results: Among 455 patients enrolled (mean age 64.9 ± 15.7 years; 25.1% females and 39.6% with CRTD), in the study period, 45 (9.9%) patients experienced a total of 86 VA; 8 patients (1.7%) required antitachycardia-pacing (ATP) and 6 (1.3%) at least one shock. In the reference period, a total of 69 events occurred in 36 patients (7.9%). Six patients (1.3%) required ATP and three (0.7%) at least one shock. The number of patients that suffered from any arrhythmic events in the study period (9.9% vs 7.9%) did not significantly differ from the reference period (χ2 = 1.09, P =.29). The main predictor of VA during the COVID-19 pandemic was the previous history of any ICD therapy (OR = 3.84, P <.001). Conclusions: No evidence of an increase of arrhythmic burden was found during the COVID-19 pandemic among patients with an ICD.
Articolo in rivista - Articolo scientifico
Scientifica
acute coronary syndrome; adult; anticoagulation; Article; cardiovascular risk; comparative study; coronavirus disease 2019; cross-sectional study; diastolic blood pressure; electrocardiography; heart arrest; heart infarction; heart injury; heart rate; heart ventricle arrhythmia; heart ventricle fibrillation; heart ventricle tachycardia; hospitalization; human; incidence; intensive care unit; ischemic heart disease; major clinical study; middle aged; nonischemic cardiomyopathy; pandemic; physical activity; prevalence; risk factor; seasonal variation;
English
Malanchini, G., Ferrari, P., Leidi, C., Ferrari, G., Racheli, M., Senni, M., et al. (2021). Ventricular arrhythmias among patients with implantable cardioverter-defibrillator during the COVID-19 pandemic. JOURNAL OF ARRHYTHMIA, 37(2), 407-413 [10.1002/joa3.12518].
Malanchini, G; Ferrari, P; Leidi, C; Ferrari, G; Racheli, M; Senni, M; De Filippo, P
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10281/373421
Citazioni
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 5
Social impact